-transparent.png){kind=logo}
Vasoactive intestinal peptide (VIP) is located in chromaffin cells of the frog adrenal gland and is able to stimulate corticosteroid secretion in amphibians. In the present study we have investigated the possible involvement of prostaglandins, microfilaments and calcium in the mechanism of action of VIP on frog adrenocortical tissue. Rana ridibunda interrenal dice were perifused with amphibian culture medium for more than 10 hours. Corticosterone and aldosterone concentrations were measured in the effluent perifusate using sensitive and specific radioimmunoassay methods. In the presence of indomethacin (5 microM), a specific blocker of prostaglandin biosynthesis, the spontaneous secretion of corticosteroids was markedly reduced (80%) but the stimulatory effect of VIP was not altered. The administration of the microfilament disrupting agent cytochalasin B (50 microM) inhibited both spontaneous and VIP-induced corticosteroid secretion. In the absence of calcium, the spontaneous level of corticosteroid was reduced to about 60% but VIP was still able to stimulate corticosteroid secretion. From these data we conclude that the integrity of the cytoskeleton is required for the secretory response of adrenocortical cells to VIP, whereas neither prostaglandins nor calcium are involved in VIP-induced adrenocortical stimulation.
F Leboulenger, and
I Perroteau, and
P Netchitailo, and
I Lihrmann, and
P Leroux, and
C Delarue, and
D H Coy, and
H Vaudry
January 1978,
Journal of clinical pathology. Supplement (Association of Clinical Pathologists),
F Leboulenger, and
I Perroteau, and
P Netchitailo, and
I Lihrmann, and
P Leroux, and
C Delarue, and
D H Coy, and
H Vaudry
January 1998,
Peptides,
F Leboulenger, and
I Perroteau, and
P Netchitailo, and
I Lihrmann, and
P Leroux, and
C Delarue, and
D H Coy, and
H Vaudry
January 2000,
Immunology today,
F Leboulenger, and
I Perroteau, and
P Netchitailo, and
I Lihrmann, and
P Leroux, and
C Delarue, and
D H Coy, and
H Vaudry
July 1978,
Gastroenterology,
F Leboulenger, and
I Perroteau, and
P Netchitailo, and
I Lihrmann, and
P Leroux, and
C Delarue, and
D H Coy, and
H Vaudry
July 1974,
Journal of the American Chemical Society,
F Leboulenger, and
I Perroteau, and
P Netchitailo, and
I Lihrmann, and
P Leroux, and
C Delarue, and
D H Coy, and
H Vaudry
October 1997,
Stress (Amsterdam, Netherlands),
F Leboulenger, and
I Perroteau, and
P Netchitailo, and
I Lihrmann, and
P Leroux, and
C Delarue, and
D H Coy, and
H Vaudry
June 1984,
Neuropeptides,
F Leboulenger, and
I Perroteau, and
P Netchitailo, and
I Lihrmann, and
P Leroux, and
C Delarue, and
D H Coy, and
H Vaudry
November 1996,
Endocrine research,
F Leboulenger, and
I Perroteau, and
P Netchitailo, and
I Lihrmann, and
P Leroux, and
C Delarue, and
D H Coy, and
H Vaudry
January 1990,
Peptides,
F Leboulenger, and
I Perroteau, and
P Netchitailo, and
I Lihrmann, and
P Leroux, and
C Delarue, and
D H Coy, and
H Vaudry
November 1994,
Neuropeptides,
